Latest Insider Transactions at Edesa Biotech, Inc. (EDSA)
This section provides a real-time view of insider transactions for Edesa Biotech, Inc. (EDSA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Edesa Biotech, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Edesa Biotech, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 02
2020
|
Velden Peter Van Der > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
70,314
+3.28%
|
$281,256
$4.0 P/Share
|
|
Oct 06
2020
|
Frank R. Oakes |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
609
+25.0%
|
$2,436
$4.0 P/Share
|
|
Mar 29
2020
|
Pardeep Nijhawan Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
2,000
+0.36%
|
$10,000
$5.23 P/Share
|